SlideShare ist ein Scribd-Unternehmen logo
1 von 25
FOCUSED. TRUSTED. GLOBAL.




EXPERTS
     Maximizing the Effectiveness of the
        Partnership with your CRO
                     Alita M Hassan, MPH
                 Director, Proposal Feasibilities
FOCUSED. TRUSTED. GLOBAL.



   Drug Development over the past 13+ years
   o 1996 – CRA – fully integrated teams – very efficient
     and effective
          Team collaboration
          Autonomy
          Execution
          Strong Site Relations
   o 2000 – Pfizer acquires Parke Davis
        Monitors De-centralized
        Start of outsourcing utilizing Functional Service Provider
         model
   o 2002 – all operations de-centralized and centralized
     to New London, CT
        Site selections, budgets, PM’s etc.
FOCUSED. TRUSTED. GLOBAL.



   Drug Development over the past 13+ years

   o Strategic Teams
        Discovery
        Early Clinical Development Teams
        Similar to the model followed by industry today
   o 2004 – Director on one of the Strategy Teams
     left in Ann Arbor –utilized Full Service Provider –
     as the continuity for the development of the
     compound was of great importance
   o 2008 – Ann Arbor site closure
FOCUSED. TRUSTED. GLOBAL.



   Current State of Affairs
   o Industry under tremendous pressure
          International competition
          Increased Regulatory Oversight
          Issues around pricing
          Investigational Product – Pipeline
   o Pressures to make the right decision
        Scientifically, Clinically, Regulatory and Commercial
   o Pressures to execute correctly on those decisions
        Selecting the right CRO – organizing
         people, resources, and timelines
        Getting things done on time, within budget, and with
         quality
FOCUSED. TRUSTED. GLOBAL.



   Different Outsourcing Models
   o Full service
        Integrated companies with global capabilities
        Handling all aspects of operations
        Advantage of integration
   o Functional service provider
        Focused on best in class
        Research team with coordination internally or by a
         lead CRO
        Advantage that if done well it provides best in class
         performance
FOCUSED. TRUSTED. GLOBAL.



   Matching Your Needs
   o Know the needs of your organization
        Global CRO/niche CRO
        Full service/functional service provider/combination
   o Ensure matching synergistic organizational
     systems
          Internal expertise
          Resources
          Knowledge
          Experience
FOCUSED. TRUSTED. GLOBAL.



   Effective Outsourcing via Partnering
   o Partnering on therapeutic basis with integration
     of strategic consulting and operations
   o Full service model preserves clear
     accountability and avoids inefficient hand-off
     between groups
FOCUSED. TRUSTED. GLOBAL.



   Strategic Alliance
   o Relationship between sponsor and CRO that is
     managed by an executive team and not by the
     study team directly involved in the project
   o Two committees are identified:
        An Operations Committee consisting of director level
         management from each functional area. Responsible for
         oversight of key performance metrics, process
         improvement and first point of escalation for project teams
        An Executive Committee consisting of senior managers
         with responsibility for oversight of the Operations
         Committee and development of strategic direction of
         each organization and how it fits into the relationship
FOCUSED. TRUSTED. GLOBAL.



   Alliance Operational Benefits
   o Ensures that proper communication,
     transparency of operational performance, and
     timely escalation of essential decision making is
     executed for achievement of success as
     measured by the Sponsor
   o Minimizes miscommunication, delays in decision
     making, and distracting political agendas from
     frustrating the project progress or setting the
     wrong priorities
FOCUSED. TRUSTED. GLOBAL.



   Alliance Operational Benefits
   o Allows operational staff to focus on their primary
     responsibilities and avoids micromanagement
     of processes by Sponsor staff with limited
     knowledge of processes and personnel at the
     CRO
   o Results in cost savings by avoiding cumbersome
     reporting and management through multiple
     study teams and resulting redundancy of effort
FOCUSED. TRUSTED. GLOBAL.



   Alliance Operational Benefits
   o Dramatically reduces costs in many instances
     by providing a framework in which the CRO
     can use appropriate risk management analysis
     to collaboratively identify labor (cost) saving
     processes tailored to the program
   o Reduces costs by minimizing CRO business
     development activities and Sponsor
     management of multiple vendors
FOCUSED. TRUSTED. GLOBAL.




EXPERTS
                  2009 Avoca Report
           The State of Clinical Outsourcing
FOCUSED. TRUSTED. GLOBAL.


   Demographics
   Sponsor respondents:

                            4   1




               23
                                         Pharmaceutical

                                         Biotechnology

                                         Device

                                         Other

                                    72
FOCUSED. TRUSTED. GLOBAL.


   Demographics
   Service provider respondents:



                            15


                                        CRO
                       4
                                        Imaging
                   8                    Laboratory

                   2                    Consulting

                                        Other
                                   71
FOCUSED. TRUSTED. GLOBAL.


   Highlights of Study
   Relationships, Relationships, Relationships…

   o Achieve greater levels of efficacy in
     outsourcing relationships
   o Maintain higher standards for service provider
     evaluation
   o Utilize performance and relationship
     management mechanisms
   o Form strategic relationships to curtail
     development and “to market” timelines
FOCUSED. TRUSTED. GLOBAL.



   Increased Efficacy in Outsourcing
   o Intensify delineation of expectations at study
     inception phase
   o Smaller budget + reduced headcount = bigger
     results
   o Performance/metric reporting
   o Implement functional “Lessons Learned”
   o Increase technology platforms for communication

   * Better measurement of provider performance and
     the use of preferred providers were ranked as the
     highest priority for sponsors’ future work
FOCUSED. TRUSTED. GLOBAL.



   Measurement Mechanisms
   o Modify current KPIs to adequately evaluate the
     service provider activity and performance
   o Adjust to account for quality of deliverables
     rather than strictly timing and quantity
   o Set rigorous standards for justifying work as
     “quality”
   o Capture relationship metrics/KRIs to increase
     efficiency
FOCUSED. TRUSTED. GLOBAL.


   Have you Formed Strategic Partnerships?
   Sponsor responses:



                            12
                                      Yes
                  10
                                      No
                                 43
                                      Don't Know

                                      N/A


                       35
FOCUSED. TRUSTED. GLOBAL.


   Have you Formed Strategic Partnerships?
   Service provider responses:



   Service provider responses:


                                          7
                                      7

                                                   Yes

                                 16
                                                   No

                                                   Don't Know

                                                   N/A

                                              73
FOCUSED. TRUSTED. GLOBAL.



   Case Study in Partnership
   o Partnering with the Sponsor, what went right?
        Proposal
           • Thorough review of protocol (protocol considerations)
           • Study feasibility
           • Realistic timeline estimates
        Award
           • Expectations
           • Responsibilities
        Execution
           •   Study start-up
           •   Site relations
           •   Recruitment process
           •   Adhere to timelines
        Outcome
FOCUSED. TRUSTED. GLOBAL.



   Case Study in Partnership
   o Introduction of Sponsor and relationship
        Roles and responsibilities
        Empowerment and trust in team
        Responsible and collaborative oversight of Sponsor
FOCUSED. TRUSTED. GLOBAL.



   Case Study in Partnership
   o Best practices from study
        Study start-up
           • Timelines meet initial deliverables
        Recruitment
           • Pre-screen at time of feasibility to ensure strong site
             selection
           • Initiate priority sites prior to investigator’s meeting
               – Encourages healthy competition
           • Relationship with sites
   o Lessons learned
        Study start-up
FOCUSED. TRUSTED. GLOBAL.



   Case Study in Partnership
   o Benefits to Sponsor in alliance model
          Continuity and knowledge of processes
          Efficiencies in costs
          Reputation in industry
          Competitive advantage in development timeline
A well thought out
 strategic partnership
between a sponsor and
  a CRO results in the
  optimization of trial
   quality, time, and
         money
FOCUSED. TRUSTED. GLOBAL.




EXPERTS            Thank you!
                     Alita M. Hassan, MPH
                 Director, Proposal Feasibilities
                         Medpace Inc
                        Cincinnati, Ohio

Weitere ähnliche Inhalte

Was ist angesagt?

Developing Enterprise Wide Analytical Capability
Developing Enterprise Wide Analytical CapabilityDeveloping Enterprise Wide Analytical Capability
Developing Enterprise Wide Analytical CapabilityElijah Ezendu
 
IT Services Development
IT Services DevelopmentIT Services Development
IT Services DevelopmentElijah Ezendu
 
Governance and relationship management
Governance and relationship management Governance and relationship management
Governance and relationship management WGroup
 
Ultimate guide to performance measurement
Ultimate guide to performance measurementUltimate guide to performance measurement
Ultimate guide to performance measurementRebecca Manjra
 
Bid to Win workshop for Seedbed - October 2015
Bid to Win workshop for Seedbed - October 2015Bid to Win workshop for Seedbed - October 2015
Bid to Win workshop for Seedbed - October 2015Matt Spry
 
G&L Scientific Position Paper Outsourcing
G&L Scientific Position Paper OutsourcingG&L Scientific Position Paper Outsourcing
G&L Scientific Position Paper OutsourcingChristinaCurry4
 
Reference models a case study for healthcare
Reference models a case study for healthcareReference models a case study for healthcare
Reference models a case study for healthcareReal IRM
 
Stakeholder Management
Stakeholder ManagementStakeholder Management
Stakeholder Managementcssa
 
Global Sourcing Collaborative Relationships
Global Sourcing Collaborative RelationshipsGlobal Sourcing Collaborative Relationships
Global Sourcing Collaborative RelationshipsJoann Martin
 
20110325_mediaOps_mega deck_scott golas
20110325_mediaOps_mega deck_scott golas20110325_mediaOps_mega deck_scott golas
20110325_mediaOps_mega deck_scott golasScott Golas
 
Mdm test lead asif iqbal
Mdm test lead asif iqbalMdm test lead asif iqbal
Mdm test lead asif iqbalasif baligar
 
Agile Vendor Selection 09 May
Agile Vendor Selection 09 MayAgile Vendor Selection 09 May
Agile Vendor Selection 09 Maynbcoenen
 
Hackett David Resume
Hackett David ResumeHackett David Resume
Hackett David Resumedchackett
 
Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...
Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...
Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...Association for Project Management
 
Thiry: Strategic Value Management 2017
Thiry: Strategic Value Management 2017Thiry: Strategic Value Management 2017
Thiry: Strategic Value Management 2017Michel Thiry
 
Sourcing strategies
Sourcing strategiesSourcing strategies
Sourcing strategiesmafecuca
 

Was ist angesagt? (20)

006
006006
006
 
001
001001
001
 
Trusted Business Advisor
Trusted Business AdvisorTrusted Business Advisor
Trusted Business Advisor
 
Developing Enterprise Wide Analytical Capability
Developing Enterprise Wide Analytical CapabilityDeveloping Enterprise Wide Analytical Capability
Developing Enterprise Wide Analytical Capability
 
IT Services Development
IT Services DevelopmentIT Services Development
IT Services Development
 
Governance and relationship management
Governance and relationship management Governance and relationship management
Governance and relationship management
 
Ultimate guide to performance measurement
Ultimate guide to performance measurementUltimate guide to performance measurement
Ultimate guide to performance measurement
 
Case Studies
Case StudiesCase Studies
Case Studies
 
Bid to Win workshop for Seedbed - October 2015
Bid to Win workshop for Seedbed - October 2015Bid to Win workshop for Seedbed - October 2015
Bid to Win workshop for Seedbed - October 2015
 
G&L Scientific Position Paper Outsourcing
G&L Scientific Position Paper OutsourcingG&L Scientific Position Paper Outsourcing
G&L Scientific Position Paper Outsourcing
 
Reference models a case study for healthcare
Reference models a case study for healthcareReference models a case study for healthcare
Reference models a case study for healthcare
 
Stakeholder Management
Stakeholder ManagementStakeholder Management
Stakeholder Management
 
Global Sourcing Collaborative Relationships
Global Sourcing Collaborative RelationshipsGlobal Sourcing Collaborative Relationships
Global Sourcing Collaborative Relationships
 
20110325_mediaOps_mega deck_scott golas
20110325_mediaOps_mega deck_scott golas20110325_mediaOps_mega deck_scott golas
20110325_mediaOps_mega deck_scott golas
 
Mdm test lead asif iqbal
Mdm test lead asif iqbalMdm test lead asif iqbal
Mdm test lead asif iqbal
 
Agile Vendor Selection 09 May
Agile Vendor Selection 09 MayAgile Vendor Selection 09 May
Agile Vendor Selection 09 May
 
Hackett David Resume
Hackett David ResumeHackett David Resume
Hackett David Resume
 
Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...
Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...
Benefits Management: it works, so why isn’t everybody doing it? Webinar, 10th...
 
Thiry: Strategic Value Management 2017
Thiry: Strategic Value Management 2017Thiry: Strategic Value Management 2017
Thiry: Strategic Value Management 2017
 
Sourcing strategies
Sourcing strategiesSourcing strategies
Sourcing strategies
 

Ähnlich wie Maximizing the Effectiveness of the Partnership with your CRO

A partnership success story.debbie elliott
A partnership success story.debbie elliottA partnership success story.debbie elliott
A partnership success story.debbie elliottMedpace
 
5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for Biotech5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for BiotechSeuss+
 
Partnerships in Clinical Trials Co-presentation with Alan Morgan
Partnerships in Clinical Trials Co-presentation with Alan Morgan Partnerships in Clinical Trials Co-presentation with Alan Morgan
Partnerships in Clinical Trials Co-presentation with Alan Morgan The Avoca Group
 
FITT Toolbox: Partnership Satisfaction Impact Survey
FITT Toolbox: Partnership Satisfaction Impact SurveyFITT Toolbox: Partnership Satisfaction Impact Survey
FITT Toolbox: Partnership Satisfaction Impact SurveyFITT
 
NeoTrials Introduction
NeoTrials Introduction NeoTrials Introduction
NeoTrials Introduction NeoTrials, LLC
 
NeoTrials Introduction
NeoTrials Introduction NeoTrials Introduction
NeoTrials Introduction NeoTrials, LLC
 
EXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight ForumEXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight ForumThe Avoca Group
 
Top 7 tips for successful benchmarking
Top 7 tips for successful benchmarkingTop 7 tips for successful benchmarking
Top 7 tips for successful benchmarkingRegina Antony
 
Avoca Award Decision Program Overview
Avoca Award Decision Program Overview Avoca Award Decision Program Overview
Avoca Award Decision Program Overview The Avoca Group
 
J&J: Transforming Study Start-up in a Global Environment
J&J: Transforming Study Start-up in a Global Environment J&J: Transforming Study Start-up in a Global Environment
J&J: Transforming Study Start-up in a Global Environment Veeva Systems
 
Principles of effective software quality management
Principles of effective software quality managementPrinciples of effective software quality management
Principles of effective software quality managementNeeraj Tripathi
 
Strategic Alliances Client Feedback Program
Strategic Alliances Client Feedback ProgramStrategic Alliances Client Feedback Program
Strategic Alliances Client Feedback ProgramThe Avoca Group
 
The Business Case: Evaluating Employee Engagement and Alignment with Organisa...
The Business Case: Evaluating Employee Engagement and Alignment with Organisa...The Business Case: Evaluating Employee Engagement and Alignment with Organisa...
The Business Case: Evaluating Employee Engagement and Alignment with Organisa...The HR Observer
 
System Level Requirements Gathering
System Level Requirements GatheringSystem Level Requirements Gathering
System Level Requirements GatheringComputing Cage
 
Benchmarking Best Practices - ProAction Group
Benchmarking Best Practices - ProAction GroupBenchmarking Best Practices - ProAction Group
Benchmarking Best Practices - ProAction GroupThe Proaction Group
 
Project Team Health Presentation
Project Team Health PresentationProject Team Health Presentation
Project Team Health Presentationwilliamskym
 
Project Team Health Presentation
Project Team Health PresentationProject Team Health Presentation
Project Team Health Presentationwilliamskym
 
Benchmarking for hrd professionals
Benchmarking for hrd professionalsBenchmarking for hrd professionals
Benchmarking for hrd professionalsSorab Sadri
 

Ähnlich wie Maximizing the Effectiveness of the Partnership with your CRO (20)

A partnership success story.debbie elliott
A partnership success story.debbie elliottA partnership success story.debbie elliott
A partnership success story.debbie elliott
 
5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for Biotech5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for Biotech
 
Partnerships in Clinical Trials Co-presentation with Alan Morgan
Partnerships in Clinical Trials Co-presentation with Alan Morgan Partnerships in Clinical Trials Co-presentation with Alan Morgan
Partnerships in Clinical Trials Co-presentation with Alan Morgan
 
FITT Toolbox: Partnership Satisfaction Impact Survey
FITT Toolbox: Partnership Satisfaction Impact SurveyFITT Toolbox: Partnership Satisfaction Impact Survey
FITT Toolbox: Partnership Satisfaction Impact Survey
 
NeoTrials Introduction
NeoTrials Introduction NeoTrials Introduction
NeoTrials Introduction
 
NeoTrials Introduction
NeoTrials Introduction NeoTrials Introduction
NeoTrials Introduction
 
EXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight ForumEXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight Forum
 
Top 7 tips for successful benchmarking
Top 7 tips for successful benchmarkingTop 7 tips for successful benchmarking
Top 7 tips for successful benchmarking
 
Avoca Award Decision Program Overview
Avoca Award Decision Program Overview Avoca Award Decision Program Overview
Avoca Award Decision Program Overview
 
J&J: Transforming Study Start-up in a Global Environment
J&J: Transforming Study Start-up in a Global Environment J&J: Transforming Study Start-up in a Global Environment
J&J: Transforming Study Start-up in a Global Environment
 
Principles of effective software quality management
Principles of effective software quality managementPrinciples of effective software quality management
Principles of effective software quality management
 
Strategic Alliances Client Feedback Program
Strategic Alliances Client Feedback ProgramStrategic Alliances Client Feedback Program
Strategic Alliances Client Feedback Program
 
The Business Case: Evaluating Employee Engagement and Alignment with Organisa...
The Business Case: Evaluating Employee Engagement and Alignment with Organisa...The Business Case: Evaluating Employee Engagement and Alignment with Organisa...
The Business Case: Evaluating Employee Engagement and Alignment with Organisa...
 
System Level Requirements Gathering
System Level Requirements GatheringSystem Level Requirements Gathering
System Level Requirements Gathering
 
Greencastle readiness assessment webinar 14 aug13
Greencastle readiness assessment webinar 14 aug13Greencastle readiness assessment webinar 14 aug13
Greencastle readiness assessment webinar 14 aug13
 
system level requirements gathering and analysis
system level requirements gathering and analysissystem level requirements gathering and analysis
system level requirements gathering and analysis
 
Benchmarking Best Practices - ProAction Group
Benchmarking Best Practices - ProAction GroupBenchmarking Best Practices - ProAction Group
Benchmarking Best Practices - ProAction Group
 
Project Team Health Presentation
Project Team Health PresentationProject Team Health Presentation
Project Team Health Presentation
 
Project Team Health Presentation
Project Team Health PresentationProject Team Health Presentation
Project Team Health Presentation
 
Benchmarking for hrd professionals
Benchmarking for hrd professionalsBenchmarking for hrd professionals
Benchmarking for hrd professionals
 

Mehr von Medpace

Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...
Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...
Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...Medpace
 
Getting Ahead of the Expanding Landscape: Radiopharmaceutical Dosimetry
Getting Ahead of the Expanding Landscape: Radiopharmaceutical DosimetryGetting Ahead of the Expanding Landscape: Radiopharmaceutical Dosimetry
Getting Ahead of the Expanding Landscape: Radiopharmaceutical DosimetryMedpace
 
Avoiding Common Pitfalls in Cell and Gene Therapy Trials
Avoiding Common Pitfalls in Cell and Gene Therapy TrialsAvoiding Common Pitfalls in Cell and Gene Therapy Trials
Avoiding Common Pitfalls in Cell and Gene Therapy TrialsMedpace
 
Chronic kidney disease how a deeper understanding of the disease is impacting...
Chronic kidney disease how a deeper understanding of the disease is impacting...Chronic kidney disease how a deeper understanding of the disease is impacting...
Chronic kidney disease how a deeper understanding of the disease is impacting...Medpace
 
Considerations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 DevelopmentConsiderations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 DevelopmentMedpace
 
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...Medpace
 
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...Medpace
 
Getting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in RadiopharmaceuticalsGetting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in RadiopharmaceuticalsMedpace
 
Challenges and Considerations in Clinical Development of "Targeted Therapies"...
Challenges and Considerations in Clinical Development of "Targeted Therapies"...Challenges and Considerations in Clinical Development of "Targeted Therapies"...
Challenges and Considerations in Clinical Development of "Targeted Therapies"...Medpace
 
The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...
The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...
The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...Medpace
 
What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...
What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...
What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...Medpace
 
Identifying High Performing Sites and Engaging Patients
Identifying High Performing Sites and Engaging PatientsIdentifying High Performing Sites and Engaging Patients
Identifying High Performing Sites and Engaging PatientsMedpace
 
Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...
Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...
Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...Medpace
 
How Advanced Therapies are Changing the Landscape of Rare Disease
How Advanced Therapies are Changing the Landscape of Rare DiseaseHow Advanced Therapies are Changing the Landscape of Rare Disease
How Advanced Therapies are Changing the Landscape of Rare DiseaseMedpace
 
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Medpace
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Medpace
 
Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...
Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...
Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...Medpace
 
Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...
Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...
Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...Medpace
 
Gene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentGene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentMedpace
 
The CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory AffairsThe CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory AffairsMedpace
 

Mehr von Medpace (20)

Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...
Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...
Wielding the Double-Edge Sword of Cardiac Biomarkers in Clinical Trials: A Di...
 
Getting Ahead of the Expanding Landscape: Radiopharmaceutical Dosimetry
Getting Ahead of the Expanding Landscape: Radiopharmaceutical DosimetryGetting Ahead of the Expanding Landscape: Radiopharmaceutical Dosimetry
Getting Ahead of the Expanding Landscape: Radiopharmaceutical Dosimetry
 
Avoiding Common Pitfalls in Cell and Gene Therapy Trials
Avoiding Common Pitfalls in Cell and Gene Therapy TrialsAvoiding Common Pitfalls in Cell and Gene Therapy Trials
Avoiding Common Pitfalls in Cell and Gene Therapy Trials
 
Chronic kidney disease how a deeper understanding of the disease is impacting...
Chronic kidney disease how a deeper understanding of the disease is impacting...Chronic kidney disease how a deeper understanding of the disease is impacting...
Chronic kidney disease how a deeper understanding of the disease is impacting...
 
Considerations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 DevelopmentConsiderations for the Next Wave of COVID-19 Development
Considerations for the Next Wave of COVID-19 Development
 
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
 
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
 
Getting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in RadiopharmaceuticalsGetting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in Radiopharmaceuticals
 
Challenges and Considerations in Clinical Development of "Targeted Therapies"...
Challenges and Considerations in Clinical Development of "Targeted Therapies"...Challenges and Considerations in Clinical Development of "Targeted Therapies"...
Challenges and Considerations in Clinical Development of "Targeted Therapies"...
 
The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...
The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...
The RACE for Children Act Will Change the Landscape for Pediatric Cancer Rese...
 
What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...
What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...
What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Re...
 
Identifying High Performing Sites and Engaging Patients
Identifying High Performing Sites and Engaging PatientsIdentifying High Performing Sites and Engaging Patients
Identifying High Performing Sites and Engaging Patients
 
Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...
Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...
Challenges and Considerations in Designing and Conducting Immuno-Oncology Cli...
 
How Advanced Therapies are Changing the Landscape of Rare Disease
How Advanced Therapies are Changing the Landscape of Rare DiseaseHow Advanced Therapies are Changing the Landscape of Rare Disease
How Advanced Therapies are Changing the Landscape of Rare Disease
 
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
 
Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...
Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...
Webinar: Getting Treatment Options to Rare Disease Patients Faster: Putting P...
 
Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...
Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...
Rare Disease Disorders and CNS Drug Development – Paving the Way for Precisio...
 
Gene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentGene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical Development
 
The CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory AffairsThe CRO-Sponsor Interaction: Regulatory Affairs
The CRO-Sponsor Interaction: Regulatory Affairs
 

Kürzlich hochgeladen

New 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateNew 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateCannaBusinessPlans
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...daisycvs
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSpanmisemningshen123
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwaitdaisycvs
 
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow ChallengesFalcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow Challengeshemanthkumar470700
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered  Building Manufacturers Hyderabad.pptxPre Engineered  Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptxRoofing Contractor
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdfTVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdfbelieveminhh
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon investment
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxCynthia Clay
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdflaloo_007
 
Cracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareCracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareWorkforce Group
 
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...ssuserf63bd7
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1kcpayne
 
BeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfBeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfDerekIwanaka1
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel
 
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Falcon Invoice Discounting
 

Kürzlich hochgeladen (20)

New 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateNew 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck Template
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow ChallengesFalcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered  Building Manufacturers Hyderabad.pptxPre Engineered  Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdfTVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
 
Cracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareCracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' Slideshare
 
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
 
Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1Katrina Personal Brand Project and portfolio 1
Katrina Personal Brand Project and portfolio 1
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
BeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfBeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdf
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
 

Maximizing the Effectiveness of the Partnership with your CRO

  • 1. FOCUSED. TRUSTED. GLOBAL. EXPERTS Maximizing the Effectiveness of the Partnership with your CRO Alita M Hassan, MPH Director, Proposal Feasibilities
  • 2. FOCUSED. TRUSTED. GLOBAL. Drug Development over the past 13+ years o 1996 – CRA – fully integrated teams – very efficient and effective  Team collaboration  Autonomy  Execution  Strong Site Relations o 2000 – Pfizer acquires Parke Davis  Monitors De-centralized  Start of outsourcing utilizing Functional Service Provider model o 2002 – all operations de-centralized and centralized to New London, CT  Site selections, budgets, PM’s etc.
  • 3. FOCUSED. TRUSTED. GLOBAL. Drug Development over the past 13+ years o Strategic Teams  Discovery  Early Clinical Development Teams  Similar to the model followed by industry today o 2004 – Director on one of the Strategy Teams left in Ann Arbor –utilized Full Service Provider – as the continuity for the development of the compound was of great importance o 2008 – Ann Arbor site closure
  • 4. FOCUSED. TRUSTED. GLOBAL. Current State of Affairs o Industry under tremendous pressure  International competition  Increased Regulatory Oversight  Issues around pricing  Investigational Product – Pipeline o Pressures to make the right decision  Scientifically, Clinically, Regulatory and Commercial o Pressures to execute correctly on those decisions  Selecting the right CRO – organizing people, resources, and timelines  Getting things done on time, within budget, and with quality
  • 5. FOCUSED. TRUSTED. GLOBAL. Different Outsourcing Models o Full service  Integrated companies with global capabilities  Handling all aspects of operations  Advantage of integration o Functional service provider  Focused on best in class  Research team with coordination internally or by a lead CRO  Advantage that if done well it provides best in class performance
  • 6. FOCUSED. TRUSTED. GLOBAL. Matching Your Needs o Know the needs of your organization  Global CRO/niche CRO  Full service/functional service provider/combination o Ensure matching synergistic organizational systems  Internal expertise  Resources  Knowledge  Experience
  • 7. FOCUSED. TRUSTED. GLOBAL. Effective Outsourcing via Partnering o Partnering on therapeutic basis with integration of strategic consulting and operations o Full service model preserves clear accountability and avoids inefficient hand-off between groups
  • 8. FOCUSED. TRUSTED. GLOBAL. Strategic Alliance o Relationship between sponsor and CRO that is managed by an executive team and not by the study team directly involved in the project o Two committees are identified:  An Operations Committee consisting of director level management from each functional area. Responsible for oversight of key performance metrics, process improvement and first point of escalation for project teams  An Executive Committee consisting of senior managers with responsibility for oversight of the Operations Committee and development of strategic direction of each organization and how it fits into the relationship
  • 9. FOCUSED. TRUSTED. GLOBAL. Alliance Operational Benefits o Ensures that proper communication, transparency of operational performance, and timely escalation of essential decision making is executed for achievement of success as measured by the Sponsor o Minimizes miscommunication, delays in decision making, and distracting political agendas from frustrating the project progress or setting the wrong priorities
  • 10. FOCUSED. TRUSTED. GLOBAL. Alliance Operational Benefits o Allows operational staff to focus on their primary responsibilities and avoids micromanagement of processes by Sponsor staff with limited knowledge of processes and personnel at the CRO o Results in cost savings by avoiding cumbersome reporting and management through multiple study teams and resulting redundancy of effort
  • 11. FOCUSED. TRUSTED. GLOBAL. Alliance Operational Benefits o Dramatically reduces costs in many instances by providing a framework in which the CRO can use appropriate risk management analysis to collaboratively identify labor (cost) saving processes tailored to the program o Reduces costs by minimizing CRO business development activities and Sponsor management of multiple vendors
  • 12. FOCUSED. TRUSTED. GLOBAL. EXPERTS 2009 Avoca Report The State of Clinical Outsourcing
  • 13. FOCUSED. TRUSTED. GLOBAL. Demographics Sponsor respondents: 4 1 23 Pharmaceutical Biotechnology Device Other 72
  • 14. FOCUSED. TRUSTED. GLOBAL. Demographics Service provider respondents: 15 CRO 4 Imaging 8 Laboratory 2 Consulting Other 71
  • 15. FOCUSED. TRUSTED. GLOBAL. Highlights of Study Relationships, Relationships, Relationships… o Achieve greater levels of efficacy in outsourcing relationships o Maintain higher standards for service provider evaluation o Utilize performance and relationship management mechanisms o Form strategic relationships to curtail development and “to market” timelines
  • 16. FOCUSED. TRUSTED. GLOBAL. Increased Efficacy in Outsourcing o Intensify delineation of expectations at study inception phase o Smaller budget + reduced headcount = bigger results o Performance/metric reporting o Implement functional “Lessons Learned” o Increase technology platforms for communication * Better measurement of provider performance and the use of preferred providers were ranked as the highest priority for sponsors’ future work
  • 17. FOCUSED. TRUSTED. GLOBAL. Measurement Mechanisms o Modify current KPIs to adequately evaluate the service provider activity and performance o Adjust to account for quality of deliverables rather than strictly timing and quantity o Set rigorous standards for justifying work as “quality” o Capture relationship metrics/KRIs to increase efficiency
  • 18. FOCUSED. TRUSTED. GLOBAL. Have you Formed Strategic Partnerships? Sponsor responses: 12 Yes 10 No 43 Don't Know N/A 35
  • 19. FOCUSED. TRUSTED. GLOBAL. Have you Formed Strategic Partnerships? Service provider responses: Service provider responses: 7 7 Yes 16 No Don't Know N/A 73
  • 20. FOCUSED. TRUSTED. GLOBAL. Case Study in Partnership o Partnering with the Sponsor, what went right?  Proposal • Thorough review of protocol (protocol considerations) • Study feasibility • Realistic timeline estimates  Award • Expectations • Responsibilities  Execution • Study start-up • Site relations • Recruitment process • Adhere to timelines  Outcome
  • 21. FOCUSED. TRUSTED. GLOBAL. Case Study in Partnership o Introduction of Sponsor and relationship  Roles and responsibilities  Empowerment and trust in team  Responsible and collaborative oversight of Sponsor
  • 22. FOCUSED. TRUSTED. GLOBAL. Case Study in Partnership o Best practices from study  Study start-up • Timelines meet initial deliverables  Recruitment • Pre-screen at time of feasibility to ensure strong site selection • Initiate priority sites prior to investigator’s meeting – Encourages healthy competition • Relationship with sites o Lessons learned  Study start-up
  • 23. FOCUSED. TRUSTED. GLOBAL. Case Study in Partnership o Benefits to Sponsor in alliance model  Continuity and knowledge of processes  Efficiencies in costs  Reputation in industry  Competitive advantage in development timeline
  • 24. A well thought out strategic partnership between a sponsor and a CRO results in the optimization of trial quality, time, and money
  • 25. FOCUSED. TRUSTED. GLOBAL. EXPERTS Thank you! Alita M. Hassan, MPH Director, Proposal Feasibilities Medpace Inc Cincinnati, Ohio

Hinweis der Redaktion

  1. Many of times these things are in place because of previous positive relationships.
  2. See astella presentation -
  3. Description of the report – Dr. Katz was part of the executive committee
  4. Who all did they reach out to- include number of each ?
  5. Curtail development by initiating discussions on the next phase of development Phase I – II or II- IIIto fu etc. Filing of NDA all data in one place.. Easy build the application and pull all data together.
  6. What does KPI/ KRI mean.
  7. Based on the organziations internal review of their needs they decided to build an alliance with Medpace as they needed not only full service capabilities with global presence but medical and regulatory expertise as well. At time of RFP – internal medical review of the protocol and provides considerations. A feasibility is performed. Each one of these steps are crucial to a successfl partnership.
  8. This relationship is no different than a marriage, things are never constant therefore the two parties must continually evolve to become better partners and communicate, communicate and communicate. One side does not take blame but both sidesa work together in solving the problem because at the end of the day we are both here to improve patient health by improving patient outcome.
  9. With the extensive experiencein ROW submissions, medace was able to meet and come ahead of schedule in getting sites up and running. As medpace has built strong relationships with investigational sites we were able to work with these sites to pre-screen patients at the time of site feasibility. This allowed Medpace to select top tier sites in addition, allowed sites to pre-screen patients so once the trial was up and running all they needed to do was to line the patients up for Informed consenting and first patient visit. As we all know that investigator’s like to be over-optimistic with their enrollment numbers however investigator’s are realizing that the competitiion for trials is becoming harder and harder therefore it is no advantaget o them to overestimate and underperform as we will not go back to them. Our investigator’s seem to perform very well for us. Initiate 5 to priority site prior to IM to have these sites startrecruiting. This provides two advantages. 1. encourages healthy competition but also allows for these 5 investigators to discuss learnings and how to recruit for such a trial.
  10. So in the end these are the benefits to a sponsor in an alliance model. Points above